Rank | Gene Set | Z-score |
---|---|---|
1 | exogenous drug catabolic process (GO:0042738) | 7.88345839 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.61800569 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.61800569 |
4 | L-phenylalanine metabolic process (GO:0006558) | 7.28102948 |
5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.28102948 |
6 | aromatic amino acid family catabolic process (GO:0009074) | 6.85221537 |
7 | epoxygenase P450 pathway (GO:0019373) | 6.81946495 |
8 | omega-hydroxylase P450 pathway (GO:0097267) | 6.51171610 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.42309261 |
10 | tryptophan catabolic process (GO:0006569) | 6.17492142 |
11 | indole-containing compound catabolic process (GO:0042436) | 6.17492142 |
12 | indolalkylamine catabolic process (GO:0046218) | 6.17492142 |
13 | kynurenine metabolic process (GO:0070189) | 6.06694359 |
14 | bile acid biosynthetic process (GO:0006699) | 5.99651077 |
15 | tryptophan metabolic process (GO:0006568) | 5.81382505 |
16 | glyoxylate metabolic process (GO:0046487) | 5.79229609 |
17 | urea metabolic process (GO:0019627) | 5.74178821 |
18 | urea cycle (GO:0000050) | 5.74178821 |
19 | negative regulation of fibrinolysis (GO:0051918) | 5.71142615 |
20 | regulation of plasminogen activation (GO:0010755) | 5.70537718 |
21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.67314528 |
22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.66233465 |
23 | intestinal cholesterol absorption (GO:0030299) | 5.60130899 |
24 | regulation of fibrinolysis (GO:0051917) | 5.50111346 |
25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.41859658 |
26 | protein carboxylation (GO:0018214) | 5.41859658 |
27 | complement activation, alternative pathway (GO:0006957) | 5.39766759 |
28 | regulation of protein activation cascade (GO:2000257) | 5.38658490 |
29 | cysteine metabolic process (GO:0006534) | 5.37031194 |
30 | sulfur amino acid catabolic process (GO:0000098) | 5.36991099 |
31 | nitrogen cycle metabolic process (GO:0071941) | 5.27799406 |
32 | serine family amino acid catabolic process (GO:0009071) | 5.14037374 |
33 | regulation of complement activation (GO:0030449) | 5.02409386 |
34 | negative regulation of blood coagulation (GO:0030195) | 4.99656790 |
35 | negative regulation of hemostasis (GO:1900047) | 4.99656790 |
36 | aromatic amino acid family metabolic process (GO:0009072) | 4.97886958 |
37 | * bile acid metabolic process (GO:0008206) | 4.97580480 |
38 | negative regulation of protein activation cascade (GO:2000258) | 4.96039128 |
39 | regulation of cholesterol esterification (GO:0010872) | 4.95747676 |
40 | reverse cholesterol transport (GO:0043691) | 4.95418725 |
41 | ethanol metabolic process (GO:0006067) | 4.90540547 |
42 | regulation of triglyceride catabolic process (GO:0010896) | 4.89942958 |
43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.89562853 |
44 | drug metabolic process (GO:0017144) | 4.89311262 |
45 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.88208930 |
46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.85399773 |
47 | protein-lipid complex remodeling (GO:0034368) | 4.85399773 |
48 | macromolecular complex remodeling (GO:0034367) | 4.85399773 |
49 | tyrosine metabolic process (GO:0006570) | 4.84306718 |
50 | homocysteine metabolic process (GO:0050667) | 4.81309076 |
51 | regulation of humoral immune response (GO:0002920) | 4.70580138 |
52 | acute-phase response (GO:0006953) | 4.67820178 |
53 | alpha-amino acid catabolic process (GO:1901606) | 4.66578989 |
54 | acylglycerol homeostasis (GO:0055090) | 4.66140216 |
55 | triglyceride homeostasis (GO:0070328) | 4.66140216 |
56 | phospholipid efflux (GO:0033700) | 4.65903321 |
57 | regulation of apoptotic cell clearance (GO:2000425) | 4.65427244 |
58 | amino-acid betaine metabolic process (GO:0006577) | 4.63826125 |
59 | negative regulation of cholesterol transport (GO:0032375) | 4.61459785 |
60 | negative regulation of sterol transport (GO:0032372) | 4.61459785 |
61 | lysine metabolic process (GO:0006553) | 4.60319429 |
62 | lysine catabolic process (GO:0006554) | 4.60319429 |
63 | negative regulation of coagulation (GO:0050819) | 4.57336903 |
64 | positive regulation of hemostasis (GO:1900048) | 4.53524535 |
65 | positive regulation of blood coagulation (GO:0030194) | 4.53524535 |
66 | cellular ketone body metabolic process (GO:0046950) | 4.48841488 |
67 | oxidative demethylation (GO:0070989) | 4.47043531 |
68 | plasma lipoprotein particle clearance (GO:0034381) | 4.46196148 |
69 | glycine metabolic process (GO:0006544) | 4.44690711 |
70 | negative regulation of wound healing (GO:0061045) | 4.44501945 |
71 | coenzyme catabolic process (GO:0009109) | 4.38667711 |
72 | indolalkylamine metabolic process (GO:0006586) | 4.37607670 |
73 | imidazole-containing compound metabolic process (GO:0052803) | 4.36104626 |
74 | cholesterol efflux (GO:0033344) | 4.29273292 |
75 | cellular amino acid catabolic process (GO:0009063) | 4.28958511 |
76 | cellular glucuronidation (GO:0052695) | 4.28871122 |
77 | cellular biogenic amine catabolic process (GO:0042402) | 4.28341347 |
78 | amine catabolic process (GO:0009310) | 4.28341347 |
79 | glutamate metabolic process (GO:0006536) | 4.26671542 |
80 | serine family amino acid metabolic process (GO:0009069) | 4.19833138 |
81 | positive regulation of coagulation (GO:0050820) | 4.16027572 |
82 | * bile acid and bile salt transport (GO:0015721) | 4.13204224 |
83 | benzene-containing compound metabolic process (GO:0042537) | 4.12458423 |
84 | ethanol oxidation (GO:0006069) | 4.11282263 |
85 | plasma lipoprotein particle assembly (GO:0034377) | 4.07702944 |
86 | low-density lipoprotein particle remodeling (GO:0034374) | 4.07545689 |
87 | cellular modified amino acid catabolic process (GO:0042219) | 4.07460249 |
88 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.07284667 |
89 | arginine metabolic process (GO:0006525) | 4.06531653 |
90 | fibrinolysis (GO:0042730) | 4.05930442 |
91 | serine family amino acid biosynthetic process (GO:0009070) | 4.02616065 |
92 | aldehyde catabolic process (GO:0046185) | 4.01068237 |
93 | protein-lipid complex subunit organization (GO:0071825) | 3.98323588 |
94 | daunorubicin metabolic process (GO:0044597) | 3.96159695 |
95 | polyketide metabolic process (GO:0030638) | 3.96159695 |
96 | doxorubicin metabolic process (GO:0044598) | 3.96159695 |
97 | phenylpropanoid metabolic process (GO:0009698) | 3.94619799 |
98 | blood coagulation, intrinsic pathway (GO:0007597) | 3.91822713 |
99 | drug catabolic process (GO:0042737) | 3.91189749 |
100 | S-adenosylmethionine metabolic process (GO:0046500) | 3.89816337 |
101 | ketone body metabolic process (GO:1902224) | 3.88616975 |
102 | negative regulation of complement activation (GO:0045916) | 3.86298355 |
103 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.83829296 |
104 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.83829296 |
105 | cofactor catabolic process (GO:0051187) | 3.82018685 |
106 | phospholipid homeostasis (GO:0055091) | 3.81492841 |
107 | uronic acid metabolic process (GO:0006063) | 3.80325070 |
108 | glucuronate metabolic process (GO:0019585) | 3.80325070 |
109 | positive regulation of lipid catabolic process (GO:0050996) | 3.80197188 |
110 | negative regulation of lipase activity (GO:0060192) | 3.79914542 |
111 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.79681855 |
112 | complement activation, classical pathway (GO:0006958) | 3.78719354 |
113 | cholesterol homeostasis (GO:0042632) | 3.77435734 |
114 | complement activation (GO:0006956) | 3.75446692 |
115 | protein activation cascade (GO:0072376) | 3.75376527 |
116 | organic acid catabolic process (GO:0016054) | 3.75231170 |
117 | carboxylic acid catabolic process (GO:0046395) | 3.75231170 |
118 | regulation of bile acid biosynthetic process (GO:0070857) | 3.71381318 |
119 | sterol homeostasis (GO:0055092) | 3.71168543 |
120 | plasma lipoprotein particle organization (GO:0071827) | 3.68712766 |
121 | acetyl-CoA metabolic process (GO:0006084) | 3.68172502 |
122 | short-chain fatty acid metabolic process (GO:0046459) | 3.65787473 |
123 | protein-lipid complex assembly (GO:0065005) | 3.65663117 |
124 | regulation of cholesterol homeostasis (GO:2000188) | 3.63751873 |
125 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.63244198 |
126 | flavonoid metabolic process (GO:0009812) | 3.58873991 |
127 | NAD biosynthetic process (GO:0009435) | 3.55856348 |
128 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.53708073 |
129 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.53708073 |
130 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.50923475 |
131 | opsonization (GO:0008228) | 3.49680498 |
132 | acute inflammatory response (GO:0002526) | 3.45533447 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.42336583 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.19830391 |
3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.00069758 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.50712573 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.31598867 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.14025891 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.85660033 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.05809376 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.03008032 |
10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08813350 |
11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0195903 |
12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98488398 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.97560376 |
14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61603643 |
15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.57814793 |
16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56499450 |
17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46021875 |
18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40080358 |
19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28110974 |
20 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.24819394 |
21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19737009 |
22 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19643290 |
23 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.17089522 |
24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16941395 |
25 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.09372332 |
26 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.07991403 |
27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01153313 |
28 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00638773 |
29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.97658927 |
30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93363757 |
31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91563546 |
32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90544993 |
33 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.90250683 |
34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84982742 |
35 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83641814 |
36 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82955407 |
37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82519245 |
38 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.82186735 |
39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82084085 |
40 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80043743 |
41 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79007489 |
42 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78392411 |
43 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75732829 |
44 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75619282 |
45 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.75039966 |
46 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74760423 |
47 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.73628594 |
48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73378432 |
49 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71421493 |
50 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70680907 |
51 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.70635735 |
52 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.69154946 |
53 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67527708 |
54 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67371825 |
55 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.65021833 |
56 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64974627 |
57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64974627 |
58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64743300 |
59 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.64586357 |
60 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.64272239 |
61 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63374745 |
62 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63145582 |
63 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.61573538 |
64 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.61399636 |
65 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60643870 |
66 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.60430670 |
67 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59922918 |
68 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.59498380 |
69 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.59461170 |
70 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.59021593 |
71 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.59008819 |
72 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.58599609 |
73 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.55739959 |
74 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.55312814 |
75 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54709357 |
76 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.54690325 |
77 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.53926797 |
78 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.52793933 |
79 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.52272060 |
80 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51620841 |
81 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.51500569 |
82 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51491466 |
83 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51236595 |
84 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50944730 |
85 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50868541 |
86 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50767906 |
87 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.50535563 |
88 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50256758 |
89 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.48581867 |
90 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.48571045 |
91 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.48503086 |
92 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48366844 |
93 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.48310003 |
94 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.48233535 |
95 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48192463 |
96 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.47208560 |
97 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46919774 |
98 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46605874 |
99 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.46165577 |
100 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.45857964 |
101 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45787291 |
102 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.45236486 |
103 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.45083028 |
104 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.44441354 |
105 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.44077069 |
106 | GATA1_19941826_ChIP-Seq_K562_Human | 0.43947253 |
107 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.43513664 |
108 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.43263051 |
109 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.43215148 |
110 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42943953 |
111 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42360204 |
112 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.42279591 |
113 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41440787 |
114 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41375786 |
115 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.41326598 |
116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.40648880 |
117 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40052119 |
118 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39510033 |
119 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.39481064 |
120 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39228357 |
121 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.39157503 |
122 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.38768160 |
123 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38428892 |
124 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37780602 |
125 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37044445 |
126 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35682668 |
127 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.34765601 |
128 | NCOR_22424771_ChIP-Seq_293T_Human | 0.33917342 |
129 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.33788025 |
130 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.33327257 |
131 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33200135 |
132 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.32746535 |
133 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.32447633 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.40983413 |
2 | MP0005360_urolithiasis | 7.57689694 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.52484106 |
4 | * MP0005365_abnormal_bile_salt | 5.95342170 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.18456000 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.29338670 |
7 | MP0003252_abnormal_bile_duct | 3.95024573 |
8 | MP0010329_abnormal_lipoprotein_level | 3.64327862 |
9 | MP0009840_abnormal_foam_cell | 3.36129992 |
10 | MP0005083_abnormal_biliary_tract | 3.13167971 |
11 | MP0003195_calcinosis | 2.82009117 |
12 | MP0005332_abnormal_amino_acid | 2.77138849 |
13 | MP0003191_abnormal_cellular_cholesterol | 2.37147725 |
14 | * MP0001666_abnormal_nutrient_absorption | 2.36073745 |
15 | * MP0000609_abnormal_liver_physiology | 2.16470900 |
16 | MP0004019_abnormal_vitamin_homeostasis | 2.14340668 |
17 | * MP0002118_abnormal_lipid_homeostasis | 2.09665900 |
18 | MP0002138_abnormal_hepatobiliary_system | 1.98238534 |
19 | MP0005319_abnormal_enzyme/_coenzyme | 1.84679710 |
20 | MP0001764_abnormal_homeostasis | 1.69155152 |
21 | MP0009697_abnormal_copulation | 1.63339373 |
22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59020900 |
23 | MP0003122_maternal_imprinting | 1.56271659 |
24 | MP0005451_abnormal_body_composition | 1.46422867 |
25 | MP0003011_delayed_dark_adaptation | 1.45144686 |
26 | * MP0003868_abnormal_feces_composition | 1.44574131 |
27 | MP0001915_intracranial_hemorrhage | 1.34736549 |
28 | MP0000566_synostosis | 1.32384068 |
29 | MP0003656_abnormal_erythrocyte_physiolo | 1.31065084 |
30 | MP0003186_abnormal_redox_activity | 1.28473296 |
31 | MP0000598_abnormal_liver_morphology | 1.19752080 |
32 | * MP0009643_abnormal_urine_homeostasis | 1.17414419 |
33 | MP0003705_abnormal_hypodermis_morpholog | 1.16764652 |
34 | MP0005647_abnormal_sex_gland | 1.14668693 |
35 | MP0000604_amyloidosis | 1.10712407 |
36 | MP0009764_decreased_sensitivity_to | 1.06328749 |
37 | MP0002254_reproductive_system_inflammat | 1.03976505 |
38 | MP0009763_increased_sensitivity_to | 1.03389832 |
39 | MP0005058_abnormal_lysosome_morphology | 0.97535168 |
40 | MP0010368_abnormal_lymphatic_system | 0.97343344 |
41 | MP0002089_abnormal_postnatal_growth/wei | 0.93132790 |
42 | MP0008469_abnormal_protein_level | 0.89721031 |
43 | * MP0009642_abnormal_blood_homeostasis | 0.86799977 |
44 | MP0005408_hypopigmentation | 0.86131543 |
45 | * MP0005636_abnormal_mineral_homeostasis | 0.83550750 |
46 | MP0006036_abnormal_mitochondrial_physio | 0.83252854 |
47 | MP0005376_homeostasis/metabolism_phenot | 0.80842876 |
48 | MP0005670_abnormal_white_adipose | 0.79387049 |
49 | MP0009765_abnormal_xenobiotic_induced | 0.79335139 |
50 | MP0002078_abnormal_glucose_homeostasis | 0.78631940 |
51 | MP0005084_abnormal_gallbladder_morpholo | 0.76597389 |
52 | MP0002876_abnormal_thyroid_physiology | 0.76384752 |
53 | MP0003879_abnormal_hair_cell | 0.74630365 |
54 | MP0005220_abnormal_exocrine_pancreas | 0.72791737 |
55 | MP0002971_abnormal_brown_adipose | 0.72352351 |
56 | MP0002282_abnormal_trachea_morphology | 0.70774263 |
57 | MP0004130_abnormal_muscle_cell | 0.70343599 |
58 | MP0003123_paternal_imprinting | 0.70097233 |
59 | MP0005334_abnormal_fat_pad | 0.69756878 |
60 | MP0003690_abnormal_glial_cell | 0.69537914 |
61 | MP0001661_extended_life_span | 0.68055647 |
62 | MP0005535_abnormal_body_temperature | 0.67635249 |
63 | MP0009053_abnormal_anal_canal | 0.67169738 |
64 | MP0005266_abnormal_metabolism | 0.65506304 |
65 | MP0005023_abnormal_wound_healing | 0.65393828 |
66 | MP0003329_amyloid_beta_deposits | 0.64922359 |
67 | MP0003172_abnormal_lysosome_physiology | 0.64542985 |
68 | MP0000639_abnormal_adrenal_gland | 0.62504507 |
69 | MP0005409_darkened_coat_color | 0.58715811 |
70 | MP0006035_abnormal_mitochondrial_morpho | 0.58513381 |
71 | MP0005448_abnormal_energy_balance | 0.55999398 |
72 | MP0004272_abnormal_basement_membrane | 0.54696883 |
73 | MP0005464_abnormal_platelet_physiology | 0.54558083 |
74 | MP0002822_catalepsy | 0.50074313 |
75 | MP0009780_abnormal_chondrocyte_physiolo | 0.49650098 |
76 | MP0005395_other_phenotype | 0.48435180 |
77 | MP0003638_abnormal_response/metabolism_ | 0.46458516 |
78 | MP0003718_maternal_effect | 0.46426751 |
79 | MP0008874_decreased_physiological_sensi | 0.46163159 |
80 | MP0008873_increased_physiological_sensi | 0.45586977 |
81 | MP0002928_abnormal_bile_duct | 0.45453455 |
82 | MP0005187_abnormal_penis_morphology | 0.44769561 |
83 | MP0002249_abnormal_larynx_morphology | 0.44094981 |
84 | MP0004782_abnormal_surfactant_physiolog | 0.43381797 |
85 | * MP0001756_abnormal_urination | 0.43053738 |
86 | MP0003436_decreased_susceptibility_to | 0.42821318 |
87 | MP0003632_abnormal_nervous_system | 0.42257114 |
88 | MP0002837_dystrophic_cardiac_calcinosis | 0.41857979 |
89 | MP0003724_increased_susceptibility_to | 0.41676449 |
90 | MP0003075_altered_response_to | 0.41616602 |
91 | MP0000920_abnormal_myelination | 0.41252792 |
92 | MP0005248_abnormal_Harderian_gland | 0.40829251 |
93 | MP0003953_abnormal_hormone_level | 0.40789369 |
94 | MP0004381_abnormal_hair_follicle | 0.39746039 |
95 | * MP0002136_abnormal_kidney_physiology | 0.39739636 |
96 | MP0008872_abnormal_physiological_respon | 0.38614304 |
97 | MP0005166_decreased_susceptibility_to | 0.38337288 |
98 | MP0009672_abnormal_birth_weight | 0.37702625 |
99 | MP0005666_abnormal_adipose_tissue | 0.37572512 |
100 | MP0005377_hearing/vestibular/ear_phenot | 0.35512247 |
101 | MP0003878_abnormal_ear_physiology | 0.35512247 |
102 | MP0005167_abnormal_blood-brain_barrier | 0.35461664 |
103 | MP0002909_abnormal_adrenal_gland | 0.35334697 |
104 | MP0005257_abnormal_intraocular_pressure | 0.35006504 |
105 | MP0000579_abnormal_nail_morphology | 0.34574390 |
106 | MP0002796_impaired_skin_barrier | 0.33768481 |
107 | MP0009115_abnormal_fat_cell | 0.33360937 |
108 | MP0001243_abnormal_dermal_layer | 0.32922553 |
109 | MP0000249_abnormal_blood_vessel | 0.32740722 |
110 | MP0004883_abnormal_blood_vessel | 0.32448932 |
111 | MP0003566_abnormal_cell_adhesion | 0.32089285 |
112 | MP0006082_CNS_inflammation | 0.31585081 |
113 | MP0000230_abnormal_systemic_arterial | 0.31430186 |
114 | MP0002933_joint_inflammation | 0.31024758 |
115 | MP0009384_cardiac_valve_regurgitation | 0.30934708 |
116 | MP0002970_abnormal_white_adipose | 0.30875616 |
117 | MP0000858_altered_metastatic_potential | 0.30461130 |
118 | MP0001853_heart_inflammation | 0.30313074 |
119 | MP0002168_other_aberrant_phenotype | 0.30240829 |
120 | MP0003943_abnormal_hepatobiliary_system | 0.30201225 |
121 | MP0002128_abnormal_blood_circulation | 0.28661395 |
122 | MP0001845_abnormal_inflammatory_respons | 0.28284812 |
123 | MP0001881_abnormal_mammary_gland | 0.28238998 |
124 | MP0006054_spinal_hemorrhage | 0.27543261 |
125 | MP0003183_abnormal_peptide_metabolism | 0.27473740 |
126 | MP0003950_abnormal_plasma_membrane | 0.25732645 |
127 | MP0005164_abnormal_response_to | 0.25631607 |
128 | MP0003631_nervous_system_phenotype | 0.25589973 |
129 | MP0002090_abnormal_vision | 0.25290636 |
130 | MP0002132_abnormal_respiratory_system | 0.24471979 |
131 | MP0002060_abnormal_skin_morphology | 0.24071325 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.50376788 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.41068147 |
3 | Intrahepatic cholestasis (HP:0001406) | 7.31992951 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.71088133 |
5 | Prolonged partial thromboplastin time (HP:0003645) | 6.63291625 |
6 | Hypobetalipoproteinemia (HP:0003563) | 6.49872796 |
7 | Xanthomatosis (HP:0000991) | 6.31701437 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.61618413 |
9 | Complement deficiency (HP:0004431) | 5.40874720 |
10 | Hypolipoproteinemia (HP:0010981) | 4.86435617 |
11 | Joint hemorrhage (HP:0005261) | 4.83305867 |
12 | Hyperammonemia (HP:0001987) | 4.61692797 |
13 | Epidermoid cyst (HP:0200040) | 4.54892573 |
14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.49765702 |
15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.45014149 |
16 | Hyperglycinemia (HP:0002154) | 4.40594284 |
17 | Abnormality of methionine metabolism (HP:0010901) | 4.32023941 |
18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.24883009 |
19 | Hypoalphalipoproteinemia (HP:0003233) | 4.24466153 |
20 | Ketosis (HP:0001946) | 4.22935798 |
21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.13483418 |
22 | Fat malabsorption (HP:0002630) | 4.13245342 |
23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.12413311 |
24 | Abnormality of complement system (HP:0005339) | 3.94679219 |
25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.88568988 |
26 | Abnormality of glycine metabolism (HP:0010895) | 3.88568988 |
27 | Hyperglycinuria (HP:0003108) | 3.87930149 |
28 | Hypoglycemic coma (HP:0001325) | 3.86275123 |
29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.86166824 |
30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.79369416 |
31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.71776295 |
32 | Hypercholesterolemia (HP:0003124) | 3.65240942 |
33 | Hyperbilirubinemia (HP:0002904) | 3.36990888 |
34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36700492 |
35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.32262671 |
36 | Steatorrhea (HP:0002570) | 3.11384320 |
37 | Delayed CNS myelination (HP:0002188) | 3.08275803 |
38 | Abnormality of serum amino acid levels (HP:0003112) | 3.07583966 |
39 | Spontaneous abortion (HP:0005268) | 3.05794894 |
40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.04553028 |
41 | Hypochromic microcytic anemia (HP:0004840) | 3.03009213 |
42 | Purpura (HP:0000979) | 3.02720949 |
43 | Hepatocellular carcinoma (HP:0001402) | 2.99792590 |
44 | Ketoacidosis (HP:0001993) | 2.98187020 |
45 | Myocardial infarction (HP:0001658) | 2.93457194 |
46 | Skin nodule (HP:0200036) | 2.81389907 |
47 | Metabolic acidosis (HP:0001942) | 2.75102080 |
48 | Systemic lupus erythematosus (HP:0002725) | 2.73475198 |
49 | Osteomalacia (HP:0002749) | 2.67522557 |
50 | Acanthocytosis (HP:0001927) | 2.64986305 |
51 | Abnormality of purine metabolism (HP:0004352) | 2.63746131 |
52 | Lethargy (HP:0001254) | 2.59541480 |
53 | Dicarboxylic aciduria (HP:0003215) | 2.55880139 |
54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.55880139 |
55 | Vascular calcification (HP:0004934) | 2.55218830 |
56 | Abnormal gallbladder morphology (HP:0012437) | 2.51488153 |
57 | Hypoglycemic seizures (HP:0002173) | 2.48338852 |
58 | Glomerulonephritis (HP:0000099) | 2.47866497 |
59 | Spastic diplegia (HP:0001264) | 2.47122490 |
60 | Abnormal gallbladder physiology (HP:0012438) | 2.45290382 |
61 | Cholecystitis (HP:0001082) | 2.45290382 |
62 | Cholelithiasis (HP:0001081) | 2.45082694 |
63 | Cerebral edema (HP:0002181) | 2.42740067 |
64 | Mitral stenosis (HP:0001718) | 2.40247441 |
65 | Gout (HP:0001997) | 2.39048980 |
66 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.37038141 |
67 | Irritability (HP:0000737) | 2.35081954 |
68 | Neonatal onset (HP:0003623) | 2.34823002 |
69 | Amyloidosis (HP:0011034) | 2.32219656 |
70 | Arthropathy (HP:0003040) | 2.26489819 |
71 | Cardiovascular calcification (HP:0011915) | 2.26209285 |
72 | Gingival bleeding (HP:0000225) | 2.24012252 |
73 | Malnutrition (HP:0004395) | 2.23559345 |
74 | Esophageal varix (HP:0002040) | 2.22170039 |
75 | Pulmonary embolism (HP:0002204) | 2.19070619 |
76 | Menorrhagia (HP:0000132) | 2.16343329 |
77 | Pancreatitis (HP:0001733) | 2.12948553 |
78 | Sensorimotor neuropathy (HP:0007141) | 2.12919187 |
79 | Brushfield spots (HP:0001088) | 2.12509314 |
80 | Late onset (HP:0003584) | 2.11136795 |
81 | Thrombophlebitis (HP:0004418) | 2.10081969 |
82 | Abnormal tarsal ossification (HP:0008369) | 2.09522042 |
83 | Enlarged kidneys (HP:0000105) | 2.09140733 |
84 | Poikilocytosis (HP:0004447) | 2.08122230 |
85 | Bifid scrotum (HP:0000048) | 2.07710749 |
86 | Abnormality of the Achilles tendon (HP:0005109) | 2.05663365 |
87 | Vomiting (HP:0002013) | 2.05279773 |
88 | Abnormality of the gallbladder (HP:0005264) | 2.03712751 |
89 | Joint swelling (HP:0001386) | 2.01579962 |
90 | Opisthotonus (HP:0002179) | 2.01114203 |
91 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.01076939 |
92 | Generalized aminoaciduria (HP:0002909) | 2.00616562 |
93 | Hemorrhage of the eye (HP:0011885) | 1.99490246 |
94 | Fair hair (HP:0002286) | 1.93964537 |
95 | Abnormality of carpal bone ossification (HP:0006257) | 1.93870032 |
96 | Rickets (HP:0002748) | 1.93539984 |
97 | Increased serum pyruvate (HP:0003542) | 1.91654819 |
98 | Abnormality of iron homeostasis (HP:0011031) | 1.89854454 |
99 | Abnormal cartilage morphology (HP:0002763) | 1.88804678 |
100 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86878525 |
101 | Renal cortical cysts (HP:0000803) | 1.85383127 |
102 | Hypophosphatemic rickets (HP:0004912) | 1.83154503 |
103 | Hydroxyprolinuria (HP:0003080) | 1.81892505 |
104 | Abnormality of proline metabolism (HP:0010907) | 1.81892505 |
105 | Hyperphosphaturia (HP:0003109) | 1.81141717 |
106 | Epistaxis (HP:0000421) | 1.80946058 |
107 | Elevated hepatic transaminases (HP:0002910) | 1.80331298 |
108 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80268364 |
109 | Alkalosis (HP:0001948) | 1.79976809 |
110 | Abnormal delivery (HP:0001787) | 1.79604761 |
111 | Status epilepticus (HP:0002133) | 1.78784820 |
112 | Nephritis (HP:0000123) | 1.75517638 |
113 | Abnormality of vitamin metabolism (HP:0100508) | 1.73562009 |
114 | Hyperglycemia (HP:0003074) | 1.73190718 |
115 | Glycosuria (HP:0003076) | 1.72853025 |
116 | Abnormality of urine glucose concentration (HP:0011016) | 1.72853025 |
117 | Increased mean platelet volume (HP:0011877) | 1.70547956 |
118 | Abnormality of glycolysis (HP:0004366) | 1.69929844 |
119 | Facial shape deformation (HP:0011334) | 1.68952280 |
120 | Potter facies (HP:0002009) | 1.68952280 |
121 | Gangrene (HP:0100758) | 1.65011287 |
122 | Reduced antithrombin III activity (HP:0001976) | 1.64300681 |
123 | Flat acetabular roof (HP:0003180) | 1.64073884 |
124 | Elevated alkaline phosphatase (HP:0003155) | 1.59998963 |
125 | Increased serum ferritin (HP:0003281) | 1.59954372 |
126 | Hypochromic anemia (HP:0001931) | 1.54396186 |
127 | Abnormal urine phosphate concentration (HP:0012599) | 1.52070880 |
128 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.50776572 |
129 | Abnormal platelet volume (HP:0011876) | 1.50545855 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.18983240 |
2 | FGFR4 | 4.59590390 |
3 | SIK1 | 4.57516171 |
4 | ERN1 | 4.36100513 |
5 | TAOK3 | 3.09682441 |
6 | INSRR | 2.98483692 |
7 | ERBB4 | 2.92146474 |
8 | PIK3CA | 2.42529489 |
9 | MAP2K4 | 2.38336244 |
10 | PKN2 | 2.30560812 |
11 | CDK12 | 2.25245429 |
12 | WNK4 | 2.18346918 |
13 | MST1R | 2.13302648 |
14 | FLT3 | 1.96888864 |
15 | MAPK11 | 1.90488285 |
16 | PDGFRA | 1.87686212 |
17 | PIK3CG | 1.80331846 |
18 | TRIB3 | 1.78737343 |
19 | FGFR1 | 1.77661562 |
20 | TYK2 | 1.70623792 |
21 | LATS1 | 1.67485022 |
22 | MAP3K2 | 1.59815548 |
23 | DAPK2 | 1.53512267 |
24 | ABL2 | 1.51537754 |
25 | TYRO3 | 1.47603908 |
26 | PTK6 | 1.46387269 |
27 | NEK9 | 1.42549584 |
28 | AKT3 | 1.41135409 |
29 | FGFR2 | 1.39937934 |
30 | FRK | 1.36951799 |
31 | KDR | 1.32555679 |
32 | NTRK3 | 1.24298151 |
33 | JAK2 | 1.23411623 |
34 | MAP3K7 | 1.20549282 |
35 | EIF2AK1 | 1.19297156 |
36 | PRKAA2 | 1.12487346 |
37 | PINK1 | 1.12382934 |
38 | MAP2K3 | 1.08109844 |
39 | GRK6 | 1.08093384 |
40 | TBK1 | 1.05221406 |
41 | ERBB2 | 1.02827971 |
42 | MAP3K10 | 1.02238164 |
43 | JAK1 | 1.02023263 |
44 | MAPK4 | 1.00141675 |
45 | WNK1 | 0.97402291 |
46 | MAP3K14 | 0.97155654 |
47 | EPHA2 | 0.94490582 |
48 | EEF2K | 0.92823621 |
49 | PRKCZ | 0.92556177 |
50 | KSR2 | 0.88475046 |
51 | MET | 0.87163792 |
52 | MAP3K3 | 0.87152633 |
53 | STK38L | 0.84889623 |
54 | EPHB1 | 0.83154623 |
55 | CDK6 | 0.82459320 |
56 | MAPK15 | 0.82309079 |
57 | MAPK12 | 0.81048801 |
58 | CSNK1E | 0.79711245 |
59 | MAP3K11 | 0.79640902 |
60 | MAPKAPK3 | 0.77312862 |
61 | PRKACG | 0.77142661 |
62 | TIE1 | 0.76161601 |
63 | EPHA3 | 0.75498435 |
64 | SIK2 | 0.74766998 |
65 | CAMK2G | 0.71216137 |
66 | CAMK1D | 0.70794141 |
67 | BCR | 0.70679322 |
68 | CSK | 0.70258305 |
69 | DYRK1B | 0.69598886 |
70 | SGK1 | 0.68799204 |
71 | GSK3A | 0.67381284 |
72 | MAP2K6 | 0.66713880 |
73 | RPS6KB1 | 0.66493049 |
74 | DDR2 | 0.66160907 |
75 | PRKAA1 | 0.65292614 |
76 | NLK | 0.65156364 |
77 | SGK3 | 0.62164573 |
78 | RIPK1 | 0.61112142 |
79 | TGFBR2 | 0.59054932 |
80 | MAPK7 | 0.58408900 |
81 | FGFR3 | 0.58094319 |
82 | IRAK3 | 0.57905439 |
83 | BRSK2 | 0.57711551 |
84 | CSF1R | 0.57218689 |
85 | SCYL2 | 0.57111721 |
86 | CDK7 | 0.56736959 |
87 | PTK2 | 0.55394311 |
88 | IKBKE | 0.53922345 |
89 | CSNK1D | 0.53878466 |
90 | PRPF4B | 0.51916073 |
91 | PRKG1 | 0.51685453 |
92 | PRKCQ | 0.51683873 |
93 | SMG1 | 0.51259266 |
94 | PDPK1 | 0.51134269 |
95 | EPHA4 | 0.48734017 |
96 | CSNK1G1 | 0.48684548 |
97 | SRC | 0.48256448 |
98 | TAOK2 | 0.47665749 |
99 | MAP3K5 | 0.46257578 |
100 | FER | 0.45942459 |
101 | NEK1 | 0.45352533 |
102 | IGF1R | 0.44357924 |
103 | SGK2 | 0.44181558 |
104 | RET | 0.43762560 |
105 | MAP2K1 | 0.43758836 |
106 | GRK1 | 0.43392172 |
107 | RPS6KA3 | 0.43387606 |
108 | CDK4 | 0.42122019 |
109 | MAP3K12 | 0.41626962 |
110 | MAP3K13 | 0.41118863 |
111 | PRKCG | 0.40648767 |
112 | MAP3K6 | 0.40062917 |
113 | PKN1 | 0.39068960 |
114 | ICK | 0.38621513 |
115 | CAMKK2 | 0.38122911 |
116 | CDC42BPA | 0.37408805 |
117 | PRKACA | 0.36767519 |
118 | MTOR | 0.35507296 |
119 | CSNK2A1 | 0.35287445 |
120 | PBK | 0.35171810 |
121 | EGFR | 0.34742887 |
122 | CSNK2A2 | 0.34706998 |
123 | ZAP70 | 0.34075977 |
124 | PRKCB | 0.34032232 |
125 | FGR | 0.33408675 |
126 | PDK1 | 0.32368623 |
127 | CAMK4 | 0.32117789 |
128 | SGK494 | 0.31168400 |
129 | SGK223 | 0.31168400 |
130 | PRKACB | 0.29725499 |
131 | CSNK1G2 | 0.29153650 |
132 | LATS2 | 0.27310151 |
133 | CSNK1G3 | 0.25805666 |
134 | PRKCA | 0.25646332 |
135 | IRAK2 | 0.25105211 |
136 | IRAK1 | 0.24281125 |
137 | CAMK1G | 0.23549603 |
138 | MAP3K1 | 0.23023718 |
139 | PAK3 | 0.21990725 |
140 | ABL1 | 0.21703999 |
141 | MAP2K2 | 0.21331865 |
142 | BMX | 0.20996969 |
143 | PDK3 | 0.20397915 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.53339013 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.64870495 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.41525379 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.36334664 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.09218326 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.78371765 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.70684564 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68817883 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62057911 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54064117 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48842319 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37411190 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24982788 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14522812 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.13314609 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.06759920 |
17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.94873535 |
18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.93114409 |
19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.92662379 |
20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92078610 |
21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89409018 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86730278 |
23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81067009 |
24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.76653225 |
25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76516749 |
26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76239409 |
27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75096310 |
28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71044003 |
29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70763477 |
30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64839450 |
31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.60325588 |
32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57357797 |
33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56192450 |
34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51208927 |
35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49720491 |
36 | Bile secretion_Homo sapiens_hsa04976 | 1.48506334 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43879961 |
38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36114877 |
39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.34270725 |
40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33825673 |
41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32662357 |
42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28247527 |
43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.21188619 |
44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21156628 |
45 | ABC transporters_Homo sapiens_hsa02010 | 1.19591234 |
46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19162261 |
47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16612752 |
48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12909105 |
49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03166684 |
50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99596814 |
51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99222529 |
52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96987659 |
53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96590663 |
54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95626239 |
55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93392851 |
56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86379987 |
57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84871274 |
58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82598980 |
59 | Lysine degradation_Homo sapiens_hsa00310 | 0.80803203 |
60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75859097 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70302417 |
62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66862862 |
63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64475481 |
64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58063343 |
65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54517855 |
66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47006639 |
67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45557895 |
68 | Pertussis_Homo sapiens_hsa05133 | 0.40521184 |
69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39878466 |
70 | Other glycan degradation_Homo sapiens_hsa00511 | 0.38797371 |
71 | Prion diseases_Homo sapiens_hsa05020 | 0.36699028 |
72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25096444 |
73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25008080 |
74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23705151 |
75 | Insulin resistance_Homo sapiens_hsa04931 | 0.22715398 |
76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22003677 |
77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21853501 |
78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20383084 |
79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15463285 |
80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09303575 |
81 | Mineral absorption_Homo sapiens_hsa04978 | 0.04903345 |
82 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.02218837 |
83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01868521 |
84 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2508297 |
85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2415205 |
86 | Amoebiasis_Homo sapiens_hsa05146 | -0.2384257 |
87 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2343951 |
88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2288005 |
89 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.2049501 |
90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1980685 |
91 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1937354 |
92 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1912538 |
93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1851324 |
94 | Hepatitis C_Homo sapiens_hsa05160 | -0.1807269 |
95 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1772482 |
96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1717520 |
97 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.1659156 |
98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1652087 |
99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1555313 |
100 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1416449 |
101 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1389443 |
102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1287103 |
103 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1031773 |
104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0883878 |
105 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0867141 |
106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0792045 |
107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0700317 |
108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0458030 |